Immediate Impact
1 by Nobel laureates 70 standout
Citing Papers
Multiple myeloma
2024 Standout
Heart failure with preserved ejection fraction: everything the clinician needs to know
2024 Standout
Works of David Yao being referenced
Elotuzumab Plus Pomalidomide and Dexamethasone for Relapsed/Refractory Multiple Myeloma: Final Overall Survival Analysis From the Randomized Phase II ELOQUENT-3 Trial
2022
Comparison of outcomes of white versus black patients hospitalized with heart failure and preserved ejection fraction**The views expressed in this article are those of the authors and do not necessarily represent the views of the Department of Veterans Affairs.
2004
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| David Yao | 104 | 104 | 65 | 170 | 153 | 26 | 667 | |
| Lorrie A. Langdale | 91 | 23 | 66 | 108 | 56 | 26 | 584 | |
| Corien Eeltink | 364 | 238 | 101 | 110 | 144 | 40 | 819 | |
| Thomas Dejoie | 138 | 253 | 89 | 198 | 224 | 53 | 728 | |
| I. B. Houston | 31 | 102 | 43 | 90 | 145 | 38 | 673 | |
| James T. Lowman | 120 | 72 | 34 | 152 | 97 | 27 | 819 | |
| Fulvia Baldassarre | 117 | 74 | 23 | 66 | 72 | 19 | 644 | |
| Robert C. Trueworthy | 90 | 190 | 28 | 358 | 108 | 28 | 822 | |
| Lisa M. Holle | 130 | 80 | 34 | 131 | 59 | 31 | 662 | |
| Mónica Tang | 155 | 81 | 23 | 58 | 155 | 51 | 662 | |
| Homa Dastani | 362 | 13 | 53 | 69 | 85 | 38 | 818 |
All Works
Login with ORCID to disown or claim papers
Loading papers...